These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24173812)
1. Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice. Yamamoto ES; Campos BL; Laurenti MD; Lago JH; Grecco Sdos S; Corbett CE; Passero LF Parasitol Res; 2014 Jan; 113(1):333-9. PubMed ID: 24173812 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis. Yamamoto ES; Campos BL; Jesus JA; Laurenti MD; Ribeiro SP; Kallás EG; Rafael-Fernandes M; Santos-Gomes G; Silva MS; Sessa DP; Lago JH; Levy D; Passero LF PLoS One; 2015; 10(12):e0144946. PubMed ID: 26674781 [TBL] [Abstract][Full Text] [Related]
3. Anti-leishmanial effects of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae). Passero LF; Bonfim-Melo A; Corbett CE; Laurenti MD; Toyama MH; de Toyama DO; Romoff P; Fávero OA; dos Grecco SS; Zalewsky CA; Lago JH Parasitol Res; 2011 Mar; 108(3):529-36. PubMed ID: 20886232 [TBL] [Abstract][Full Text] [Related]
4. Caryocar coriaceum extracts exert leishmanicidal effect acting in promastigote forms by apoptosis-like mechanism and intracellular amastigotes by Nrf2/HO-1/ferritin dependent response and iron depletion: Leishmanicidal effect of Caryocar coriaceum leaf exracts. Tomiotto-Pellissier F; Alves DR; Miranda-Sapla MM; de Morais SM; Assolini JP; da Silva Bortoleti BT; Gonçalves MD; Cataneo AHD; Kian D; Madeira TB; Yamauchi LM; Nixdorf SL; Costa IN; Conchon-Costa I; Pavanelli WR Biomed Pharmacother; 2018 Feb; 98():662-672. PubMed ID: 29294453 [TBL] [Abstract][Full Text] [Related]
5. In vitro effects of triterpenic acids from olive leaf extracts on the mitochondrial membrane potential of promastigote stage of Leishmania spp. Sifaoui I; López-Arencibia A; Martín-Navarro CM; Ticona JC; Reyes-Batlle M; Mejri M; Jiménez AI; Lopez-Bazzocchi I; Valladares B; Lorenzo-Morales J; Abderabba M; Piñero JE Phytomedicine; 2014 Oct; 21(12):1689-94. PubMed ID: 25442278 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of ursolic acid in experimental visceral leishmaniasis. Jesus JA; Fragoso TN; Yamamoto ES; Laurenti MD; Silva MS; Ferreira AF; Lago JH; Santos-Gomes G; Passero LF Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):1-11. PubMed ID: 27984757 [TBL] [Abstract][Full Text] [Related]
7. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis. Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783 [TBL] [Abstract][Full Text] [Related]
9. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae). Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090 [TBL] [Abstract][Full Text] [Related]
10. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate. Ferreira BA; Coser EM; de la Roca S; Aoki JI; Branco N; Soares GHC; Lima MIS; Coelho AC PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917 [TBL] [Abstract][Full Text] [Related]
14. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis. Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166 [TBL] [Abstract][Full Text] [Related]
15. Effect of HIV protease inhibitors on New World Leishmania. Demarchi IG; Silveira TG; Ferreira IC; Lonardoni MV Parasitol Int; 2012 Dec; 61(4):538-44. PubMed ID: 22579524 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Santos DM; Petersen AL; Celes FS; Borges VM; Veras PS; de Oliveira CI PLoS Negl Trop Dis; 2014 Oct; 8(10):e3275. PubMed ID: 25340794 [TBL] [Abstract][Full Text] [Related]
19. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis. Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866 [TBL] [Abstract][Full Text] [Related]